Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors-Reference-Cited by-同舟云学术

Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors

Published:2021-07 Issue: Volume:152 Page:78-89
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lynch Seodhna M.,Russell Niamh M.^ORCID,Barron Stephen,Wang Chan-Ju A.,Loughman Tony^ORCID,Dynoodt Peter,Fender Bozena,Lopez-Ruiz Cesar^ORCID,O'Grady Anthony,Sheehan Katherine M.,Fay Joanna^ORCID,Amberger-Murphy Verena^ORCID,Saha Anurati,Klinger Rut,Gonzalez Claudia A.,Al-Attar Nebras^ORCID,Rahman Arman,O'Leary Desmond,Lanigan Fiona T.,Bracken Adrian P.^ORCID,Crown John,Kelly Catherine M.,O'Connor Darran P.,Gallagher William M.

Funder

Royal College of Surgeons in Ireland

University College Dublin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. World Health Organization. International agency for research on cancer. Global cancer observatory. http://gco.iarc.fr/. Accessed May 7, 2021.

2. Breast cancer facts & figures 2017-2018,2017

3. Early and locally advanced breast cancer: diagnosis and management,2018

4. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer,2018

5. The Nottingham Prognostic Index in primary breast cancer;Galea;Breast Canc Res Treat,1992

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Select gene mutations associated with survival outcomes in ER‐positive ERBB2‐negative early‐stage invasive breast cancer: A single‐institutional tissue bank study;Cancer Medicine;2024-07

2. Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients;International Journal of Molecular Sciences;2023-09-11

3. Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer;Clinical Chemistry;2022-03-21